- Home
- WTI vs ENTA Comparison
WTI vs ENTA Comparison
Compare WTI & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WTI
- ENTA
- Stock Information
- Founded
- WTI 1983
- ENTA 1995
- Country
- WTI United States
- ENTA United States
- Employees
- WTI N/A
- ENTA N/A
- Industry
- WTI Oil & Gas Production
- ENTA Biotechnology: Pharmaceutical Preparations
- Sector
- WTI Energy
- ENTA Health Care
- Exchange
- WTI Nasdaq
- ENTA Nasdaq
- Market Cap
- WTI 172.8M
- ENTA 154.0M
- IPO Year
- WTI 2005
- ENTA 2013
- Fundamental
- Price
- WTI $1.17
- ENTA $5.58
- Analyst Decision
- WTI
- ENTA Buy
- Analyst Count
- WTI 0
- ENTA 4
- Target Price
- WTI N/A
- ENTA $17.25
- AVG Volume (30 Days)
- WTI 1.6M
- ENTA 265.7K
- Earning Date
- WTI 05-06-2025
- ENTA 05-05-2025
- Dividend Yield
- WTI 3.42%
- ENTA N/A
- EPS Growth
- WTI N/A
- ENTA N/A
- EPS
- WTI N/A
- ENTA N/A
- Revenue
- WTI $525,260,999.00
- ENTA $66,590,999.00
- Revenue This Year
- WTI $3.79
- ENTA N/A
- Revenue Next Year
- WTI N/A
- ENTA N/A
- P/E Ratio
- WTI N/A
- ENTA N/A
- Revenue Growth
- WTI N/A
- ENTA N/A
- 52 Week Low
- WTI $1.09
- ENTA $4.09
- 52 Week High
- WTI $2.84
- ENTA $17.24
- Technical
- Relative Strength Index (RSI)
- WTI 36.02
- ENTA 52.26
- Support Level
- WTI $1.13
- ENTA $5.33
- Resistance Level
- WTI $1.20
- ENTA $5.75
- Average True Range (ATR)
- WTI 0.08
- ENTA 0.43
- MACD
- WTI 0.01
- ENTA 0.16
- Stochastic Oscillator
- WTI 29.55
- ENTA 89.76
About WTI W&T Offshore Inc.
W&T Offshore Inc is an oil and gas exploration and production company. The company's exploration operations are focused in the Gulf of Mexico, where it drills for oil and gas. The company engages in both deepwater drilling and shallow-water shelf drilling. W&T Offshore extracts crude oil, natural gas, and natural gas liquids, which are then sold directly at the wellhead. Overall, crude oil accounts for the majority of company's revenue, with natural gas accounting for a much smaller portion.
About ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.